NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions

NSD3 (nuclear receptor-binding SET domain protein 3) is a member of the NSD histone methyltransferase family of proteins. In recent years, it has been identified as a potential oncogene in certain types of cancer. The NSD3 gene encodes three isoforms, the long version (NSD3L), a short version (NSD3S...

Full description

Bibliographic Details
Main Authors: Yanara Nuñez, Sebastian Vera, Victor Baeza, Valentina Gonzalez-Pecchi
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/2/944
_version_ 1797339830860906496
author Yanara Nuñez
Sebastian Vera
Victor Baeza
Valentina Gonzalez-Pecchi
author_facet Yanara Nuñez
Sebastian Vera
Victor Baeza
Valentina Gonzalez-Pecchi
author_sort Yanara Nuñez
collection DOAJ
description NSD3 (nuclear receptor-binding SET domain protein 3) is a member of the NSD histone methyltransferase family of proteins. In recent years, it has been identified as a potential oncogene in certain types of cancer. The NSD3 gene encodes three isoforms, the long version (NSD3L), a short version (NSD3S) and the WHISTLE isoforms. Importantly, the NSD3S isoform corresponds to the N-terminal region of the full-length protein, lacking the methyltransferase domain. The chromosomal location of NSD3 is frequently amplified across cancer types, such as breast, lung, and colon, among others. Recently, this amplification has been correlated to a chromothripsis event, that could explain the different NSD3 alterations found in cancer. The fusion proteins containing NSD3 have also been reported in leukemia (NSD3-NUP98), and in NUT (nuclear protein of the testis) midline carcinoma (NSD3-NUT). Its role as an oncogene has been described by modulating different cancer pathways through its methyltransferase activity, or the short isoform of the protein, through protein interactions. Specifically, in this review we will focus on the functions that have been characterized as methyltransferase dependent, and those that have been correlated with the expression of the NSD3S isoform. There is evidence that both the NSD3L and NSD3S isoforms are relevant for cancer progression, establishing NSD3 as a therapeutic target. However, further functional studies are needed to differentiate NSD3 oncogenic activity as dependent or independent of the catalytic domain of the protein, as well as the contribution of each isoform and its clinical significance in cancer progression.
first_indexed 2024-03-08T09:54:05Z
format Article
id doaj.art-ad37cbbf2f7d4a58b2b2c1249b905ddf
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-08T09:54:05Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ad37cbbf2f7d4a58b2b2c1249b905ddf2024-01-29T13:55:43ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-01-0125294410.3390/ijms25020944NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific FunctionsYanara Nuñez0Sebastian Vera1Victor Baeza2Valentina Gonzalez-Pecchi3Biomedical Science Research Laboratory, Department of Basic Sciences, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción 4090541, ChileBiomedical Science Research Laboratory, Department of Basic Sciences, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción 4090541, ChileBiomedical Science Research Laboratory, Department of Basic Sciences, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción 4090541, ChileBiomedical Science Research Laboratory, Department of Basic Sciences, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción 4090541, ChileNSD3 (nuclear receptor-binding SET domain protein 3) is a member of the NSD histone methyltransferase family of proteins. In recent years, it has been identified as a potential oncogene in certain types of cancer. The NSD3 gene encodes three isoforms, the long version (NSD3L), a short version (NSD3S) and the WHISTLE isoforms. Importantly, the NSD3S isoform corresponds to the N-terminal region of the full-length protein, lacking the methyltransferase domain. The chromosomal location of NSD3 is frequently amplified across cancer types, such as breast, lung, and colon, among others. Recently, this amplification has been correlated to a chromothripsis event, that could explain the different NSD3 alterations found in cancer. The fusion proteins containing NSD3 have also been reported in leukemia (NSD3-NUP98), and in NUT (nuclear protein of the testis) midline carcinoma (NSD3-NUT). Its role as an oncogene has been described by modulating different cancer pathways through its methyltransferase activity, or the short isoform of the protein, through protein interactions. Specifically, in this review we will focus on the functions that have been characterized as methyltransferase dependent, and those that have been correlated with the expression of the NSD3S isoform. There is evidence that both the NSD3L and NSD3S isoforms are relevant for cancer progression, establishing NSD3 as a therapeutic target. However, further functional studies are needed to differentiate NSD3 oncogenic activity as dependent or independent of the catalytic domain of the protein, as well as the contribution of each isoform and its clinical significance in cancer progression.https://www.mdpi.com/1422-0067/25/2/944cancermolecular oncologyoncogenesNSD3NSD3S
spellingShingle Yanara Nuñez
Sebastian Vera
Victor Baeza
Valentina Gonzalez-Pecchi
NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
International Journal of Molecular Sciences
cancer
molecular oncology
oncogenes
NSD3
NSD3S
title NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
title_full NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
title_fullStr NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
title_full_unstemmed NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
title_short NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
title_sort nsd3 in cancer unraveling methyltransferase dependent and isoform specific functions
topic cancer
molecular oncology
oncogenes
NSD3
NSD3S
url https://www.mdpi.com/1422-0067/25/2/944
work_keys_str_mv AT yanaranunez nsd3incancerunravelingmethyltransferasedependentandisoformspecificfunctions
AT sebastianvera nsd3incancerunravelingmethyltransferasedependentandisoformspecificfunctions
AT victorbaeza nsd3incancerunravelingmethyltransferasedependentandisoformspecificfunctions
AT valentinagonzalezpecchi nsd3incancerunravelingmethyltransferasedependentandisoformspecificfunctions